Nader Al‐Dewik
Hamad Medical Corporation(QA)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, SARS-CoV-2 and COVID-19 Research, Gestational Diabetes Research and Management
Most-Cited Works
- → High diagnostic yield of clinical exome sequencing in Middle Eastern patients with Mendelian disorders(2015)189 cited
- → Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations(2015)156 cited
- → Effects of consanguinity in a cohort of subjects with certain genetic disorders in Qatar(2019)101 cited
- → Risk factors diagnosis prognosis and treatment of autism(2020)92 cited
- → Children’s prolonged exposure to the toxic stress of war trauma in the Middle East(2020)65 cited
- → Optimizing Clinical Workflow Using Precision Medicine and Advanced Data Analytics(2023)57 cited
- → Clinical exome sequencing in 509 Middle Eastern families with suspected Mendelian diseases: The Qatari experience(2019)54 cited
- → Prevalence, predictors, and outcomes of major congenital anomalies: A population-based register study(2023)50 cited
- → Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals(2021)44 cited
- → Is Adherence to Imatinib Mesylate Treatment among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?(2016)38 cited